Help Privacy Policy Disclaimer
  Advanced SearchBrowse




Journal Article

FKBPs and their role in neuronal signaling


Hausch,  Felix
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available

Hausch, F. (2015). FKBPs and their role in neuronal signaling. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1850(10 (Special Issue)), 2035-2040. doi:10.1016/j.bbagen.2015.01.012.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0029-B317-E
Background: Ligands for FK506-binding proteins, also referred to as neuroimmunophilin ligands, have repeatedly been described as neuritotrophic, neuroprotective or neuroregenerative agents. However, the precise molecular mechanism of action underlying the observed effects has remained elusive, which eventually led to a reduced interest in FKBP ligand development. Scope of review: A survey is presented on the pharmacology of neuroimmunophilin ligands, of the current understanding of individual FKBP homologs in neuronal processes and an assessment of their potential as drug targets for CNS disorders. Major conclusions: FKBP51 is the major target accounting for the neuritotrophic effect of neuroimmunophilin ligands. Selectivity against the homolog FKBP52 is essential for optimal neuritotrophic efficacy. General significance: Selectivity within the FKBP family, in particular selective inhibition of FKBP12 or FKBP51, is possible. FKBP51 is a pharmacologically tractable target for stress-related disorders. The role of FKBPs in neurodegeneration remains to be clarified. This article is part of a Special Issue entitled Proline-directed Foldases: Cell Signaling Catalysts and Drug Targets. (C) 2015 Elsevier B.V. All rights reserved.